Rationale for Left Atrial Appendage Exclusion.
Left atrial appendage (LAA) is the source of most systemic emboli in patients with atrial fibrillation. Oral anticoagulant therapy reduces stroke risk by two-thirds. New oral agents have advantages over warfarin but are associated with bleeding and drug intolerance. Device therapy for atrial appendage ligation or occlusion is an alternative to drug therapy, without the cumulative incidence of bleeding or the need for anticoagulation. In the more than half century since the early reports of surgical LAA excision, the author has added considerable detail to our understanding of the rationale for LAA exclusion, which constitutes the subject of this article.